Valuation: Monto Minerals Ltd

Market Cap 39.16M 27.47M 24.16M 22.78M 20.78M 38.86M 2.64B 273M 106M 1.34B 103M 101M 4.37B P/E 2025
-3.77x
P/E 2026 -8.1x
Enterprise Value 35.75M 25.08M 22.06M 20.79M 18.97M 35.48M 2.41B 250M 96.69M 1.23B 94.15M 92.1M 3.99B EV / Sales 2025
21.1x
EV / Sales 2026 1,648x
Free-Float
17.5%
Yield 2025 *
-
Yield 2026 -
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 16/01/1994
Chief Executive Officer - 10/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 20/10/2025
Director/Board Member - 20/10/2025
Chairman - 25/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+1.51%+4.20%-1.12%+35.30% 44.5B
-1.63%-5.05%-47.92%+126.16% 11.99B
+2.63%-1.66%-7.11%+112.55% 5.38B
+2.68%-1.84%+41.08% - 4.23B
-3.21%-6.60% - - 2.05B
+0.12%+1.26%+6.96%-33.70% 1.51B
+0.08%-1.95%-36.69% - 1.01B
+0.62%-3.75%+8.69%+152.85% 965M
-1.14%-2.05%+30.51%+42.69% 859M
Average +0.44%-2.72%-0.70%+72.64% 8.06B
Weighted average by Cap. +0.14%+1.06%-6.82%+58.63%

Financials

2025 2026
Net sales 322K 226K 199K 187K 171K 320K 21.68M 2.25M 871K 11.03M 848K 830K 35.9M 47.63K 33.41K 29.38K 27.7K 25.27K 47.26K 3.21M 332K 129K 1.63M 125K 123K 5.31M
Net income -1.45M -1.02M -893K -842K -768K -1.44M -97.47M -10.1M -3.92M -49.61M -3.81M -3.73M -161M -3.65M -2.56M -2.25M -2.12M -1.94M -3.62M -246M -25.49M -9.88M -125M -9.62M -9.41M -407M
Net Debt -25.17K -17.65K -15.53K -14.64K -13.35K -24.97K -1.69M -176K -68.06K -862K -66.27K -64.83K -2.81M -3.41M -2.39M -2.1M -1.98M -1.81M -3.38M -230M -23.8M -9.22M -117M -8.98M -8.78M -380M
Logo Monto Minerals Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-